Women's Health

Biomarker panels specific to different ethnicities may allow health care providers to better assess individuals women’s personal reproductive potential, according to a systematic review published in Reproductive Sciences.

Breast-conserving surgery resulted in high overall and disease-free survival rates among patients with breast cancer who underwent surgery in China, according to a cohort study published in JAMA Network Open.

Black and Hispanic premenopausal women are more likely to experience severe bleeding and other symptoms related to noncancerous gynecologic conditions before undergoing hysterectomy compared with white women.

DANA POINT, Calif. — Clinicians must use a tailored approach when treating women with HF, who have risk factors, biomarkers and manifestations of disease that are often distinctly different from men, according to a speaker.

ANI Pharmaceuticals received FDA approval for an abbreviated new drug application for estradiol gel, 0.1%, according to a company press release.

Uterine fibroids are common hormone-dependent tumors that can develop after puberty, with likelihood increasing with age and regressing after menopause when estrogen and progesterone are no longer produced.

In a recent survey, one-fifth of respondents reported negative health care experiences during their pregnancy and delivery, according to a newly released CDC Vital Signs report.

Women who gave birth following use of assisted reproductive technology did not have an increased risk for CVD over a median follow-up of 11 years compared with women who conceived naturally, researchers reported.

Menstrual inequity is experienced worldwide, even in the U.S., where stigmas surrounding menstruation continue affecting all forms of menstrual inequities such as period poverty, access issues and legal issues, according to experts.

The 5th U.S. Circuit Court of Appeals ruled on restrictions on the abortion drug mifepristone, but this ruling will not go into effect unless it is upheld by the U.S. Supreme Court.